Ron Xu

Ron Xu is an experienced leader in clinical pharmacology and drug metabolism and pharmacokinetics (DMPK) with over 25 years in the biotechnology and pharmaceutical industries. Currently serving as Executive Director and Senior Director of Clinical Pharmacology at ORIC Pharmaceuticals since January 2019, Ron Xu previously held senior positions at ACEA Therapeutics, Inc. and Takeda California, Inc., where responsibilities included the management and design of clinical DMPK studies and drug discovery support through bioanalysis and pharmacokinetics. Early in the career at Deltagen/BMS/Dupont/CombiChem, Ron Xu was instrumental in initiating ADME efforts and developing high-throughput technologies for early drug discovery. Educational qualifications include a Ph.D. in Analytical Chemistry from Kansas State University and a Master's degree in Analytical Chemistry from Xiamen University.